NPPC and Severe short stature: Vosoritide (VoxzogoTM) (Figure 6), which has been approved for the treatment of achondroplasia (Dwarfism), is an analog of human C-type natriuretic peptide (CNP) that includes 37 aa with two additional resides, Pro and Gly, and the N-terminal.